NCT02080312View on ClinicalTrials.gov

Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Meniere's Disease
Interventions
DRUG

Magnevist (gadopentetate dimeglumine)

Trial Locations (1)

92103

UC San Diego Health System, San Diego

All Listed Sponsors
collaborator

American Society of Head and Neck Radiology

UNKNOWN

lead

University of California, San Diego

OTHER

NCT02080312 - Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent | Biotech Hunter | Biotech Hunter